These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38892158)

  • 1. Neuroinflammation: From Molecular Basis to Therapy.
    Zanella I
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytes ACLYmate to chronic neuroinflammation.
    Champagne-Jorgensen K; Gommerman J
    Trends Immunol; 2024 May; 45(5):320-321. PubMed ID: 38632002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12 in control of neuroinflammation.
    Momcilović M; Mostarica-Stojković M; Miljković D
    Immunol Res; 2012 Apr; 52(1-2):53-63. PubMed ID: 22392052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
    Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
    Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology.
    Voet S; Prinz M; van Loo G
    Trends Mol Med; 2019 Feb; 25(2):112-123. PubMed ID: 30578090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis.
    DiSano KD; Royce DB; Gilli F; Pachner AR
    Front Immunol; 2019; 10():1821. PubMed ID: 31428102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
    Mc Guire C; Prinz M; Beyaert R; van Loo G
    Trends Mol Med; 2013 Oct; 19(10):604-13. PubMed ID: 24007818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of system x
    Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
    J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into adaptive immunity in chronic neuroinflammation.
    Siffrin V; Brandt AU; Herz J; Zipp F
    Adv Immunol; 2007; 96():1-40. PubMed ID: 17981203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS immune surveillance and neuroinflammation: endocannabinoids keep control.
    Wolf SA; Tauber S; Ullrich O
    Curr Pharm Des; 2008; 14(23):2266-78. PubMed ID: 18781977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations.
    Radandish M; Khalilian P; Esmaeil N
    Front Immunol; 2021; 12():667705. PubMed ID: 34489926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global and 3D spatial assessment of neuroinflammation in rodent models of Multiple Sclerosis.
    Gupta S; Utoft R; Hasseldam H; Schmidt-Christensen A; Hannibal TD; Hansen L; Fransén-Pettersson N; Agarwal-Gupta N; Rozell B; Andersson A; Holmberg D
    PLoS One; 2013; 8(10):e76330. PubMed ID: 24124545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trafficking of lymphocytes into the CNS.
    Schwab N; Schneider-Hohendorf T; Wiendl H
    Oncotarget; 2015 Jul; 6(20):17863-4. PubMed ID: 26255669
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis.
    Hassani A; Reguraman N; Shehab S; Khan G
    Front Immunol; 2021; 12():764937. PubMed ID: 34899715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.
    Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN
    J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells in multiple sclerosis.
    Wekerle H
    Autoimmunity; 2017 Feb; 50(1):57-60. PubMed ID: 28166681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets.
    Mammana S; Fagone P; Cavalli E; Basile MS; Petralia MC; Nicoletti F; Bramanti P; Mazzon E
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29533975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.